BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11744492)

  • 1. Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgery.
    Gollob JA; Upton MP; DeWolf WC; Atkins MB
    Urology; 2001 Dec; 58(6):1058. PubMed ID: 11744492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A renal cancer with intermediate characteristics between collecting (Bellini) duct carcinoma and urothelial carcinoma: case report and review of the literature.
    Maestroni U; Ferretti S; Dinale F; Froio E; Pilato FP; Ciuffreda M; Mellissari M; Cortellini P
    Tumori; 2006; 92(6):545-8. PubMed ID: 17260499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.
    Bylow KA; Atkins MB; Posadas EM; Stadler WM; McDermott DF
    Clin Genitourin Cancer; 2009 Jan; 7(1):39-42. PubMed ID: 19213667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of primary retroperitoneal mucinous adenocarcinoma: a case report.
    Cupp JS; Illeck J; Rahbar N; Rettenmaier MA; Goldstein BH
    J Reprod Med; 2013; 58(1-2):85-8. PubMed ID: 23447927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinoma of the Bellini collecting duct in paediatric patients: a case report and review of the literature].
    Gurrera A; Amico P; Di Cataldo A; Vasquez E; Magro G
    Pathologica; 2007 Oct; 99(5):301-5. PubMed ID: 18354951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma?
    Méjean A; Rouprêt M; Larousserie F; Hopirtean V; Thiounn N; Dufour B
    J Urol; 2003 Apr; 169(4):1287-90. PubMed ID: 12629344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged remission of recurrent cervical carcinoma following paclitaxel and carboplatin chemotherapy with paclitaxel maintenance chemotherapy.
    Micha JP; Sassoon AF; Wong H; Goldstein BH
    Anticancer Drugs; 2015 Aug; 26(7):793-6. PubMed ID: 25933247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nivolumab therapy for metastatic collecting duct carcinoma after nephrectomy: A case report.
    Yasuoka S; Hamasaki T; Kuribayashi E; Nagasawa M; Kawaguchi T; Nagashima Y; Kondo Y
    Medicine (Baltimore); 2018 Nov; 97(45):e13173. PubMed ID: 30407350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group.
    Bamias A; Deliveliotis Ch; Fountzilas G; Gika D; Anagnostopoulos A; Zorzou MP; Kastritis E; Constantinides C; Kosmidis P; Dimopoulos MA
    J Clin Oncol; 2004 Jun; 22(11):2150-4. PubMed ID: 15169801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoma of the urachus: a case report].
    Hasegawa Y; Kato Y; Wakita T; Hayashi N; Tsukamoto K
    Hinyokika Kiyo; 2005 Mar; 51(3):191-4. PubMed ID: 15852675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin.
    Le TD; Yamada SD; Rutgers JL; DiSaia PJ
    Gynecol Oncol; 1999 Jun; 73(3):461-3. PubMed ID: 10366480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage paclitaxel chemotherapy for metastatic collecting duct carcinoma of the kidney.
    Bagrodia A; Gold R; Handorf C; Liman A; Derweesh IH
    Can J Urol; 2008 Dec; 15(6):4425-7. PubMed ID: 19046497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of chemotherapy successfulness of platina/taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II and III stage.
    Ljuca D; Fatusić Z; Iljazović E; Ahmetović B
    Bosn J Basic Med Sci; 2007 May; 7(2):111-6. PubMed ID: 17489744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma.
    Airoldi M; Gabriele P; Gabriele AM; Garzaro M; Raimondo L; Pedani F; Beatrice F; Pecorari G; Giordano C
    Cancer Chemother Pharmacol; 2011 May; 67(5):1027-34. PubMed ID: 20644931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of advanced clear cell carcinoma of the endometrium that responded remarkably to neoadjuvant chemotherapy of combination carboplatin plus weekly paclitaxel].
    Takami M; Ohta Y; Nakayama Y; Fukai H; Matsumoto H; Takimoto T; Sakamoto H; Yamamoto T
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):457-60. PubMed ID: 17353643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Fountzilas G; Aravantinos G; Kalofonos HP; Efstathiou E; Salamalekis E; Farmakis D; Skarlos D; Briasoulis E; Economopoulos T; Dimopoulos MA
    Gynecol Oncol; 2005 May; 97(2):436-41. PubMed ID: 15863142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous Low-Dose Oral Cyclophosphamide and Methotrexate as Maintenance Therapy in Patients With Advanced Ovarian Carcinoma After Complete Clinical Response to Platinum and Paclitaxel Chemotherapy.
    El-Husseiny K; Motawei H; Ali MS
    Int J Gynecol Cancer; 2016 Mar; 26(3):437-42. PubMed ID: 26825824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
    Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
    Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.